Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Completed
National Cancer Institute (NCI)
Phase 2
1995-10-01
RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or
recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer
in patients with Barrett's esophagus.
PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine
in preventing cancer in patients with Barrett's esophagus.
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Completed
University of Michigan Cancer Center
Phase 2
1995-10-01
RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or
recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer
in patients with Barrett's esophagus.
PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine
in preventing cancer in patients with Barrett's esophagus.
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Completed
University of Michigan Rogel Cancer Center
Phase 2
1995-10-01
RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or
recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer
in patients with Barrett's esophagus.
PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine
in preventing cancer in patients with Barrett's esophagus.
Eflornithine in Treating Patients With Bladder Cancer
Completed
National Cancer Institute (NCI)
Phase 3
1999-02-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known if eflornithine is more effective than no
further therapy in treating bladder cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of eflornithine in
treating patients who have newly diagnosed or recurrent bladder cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.